We use non-essential cookies (including anonymous analytics) to help us understand if our website is working well and to learn what content is most useful to visitors. We also use some cookies which are essential for our platform to work and help us to provide you with the best experience possible. You can accept or reject our non-essential cookies and change your mind at any time. To learn more, please read our cookies policy.

Update cookie preferences

Ovarian cancer treatment

Information on chemotherapy, surgery, radiotherapy, hormone treatment and more

The treatment pathway describes the journey of care and medical treatment a patient begins after receiving a diagnosis. Each woman’s experience of the ovarian cancer treatment pathway is different. 

Ovarian cancer is a complex disease and your treatment will depend on the type of cancer you have, its stage and grade, and your general health. 

Once you have an ovarian cancer diagnosis you will be assigned to a multidisciplinary team (MDT) of gynaecological cancer specialists. This specialist oncology team overseeing your treatment will include a gynaecological oncologist and a clinical nurse specialist (CNS). 

The team will meet to discuss and agree on the most appropriate treatment plan for you, which your oncologist will then explain to you at your next appointment. The treatment will only go ahead with your consent. Don’t be afraid to ask your doctor questions or ask them to repeat what they say until you understand your treatment and feel comfortable with the next steps. 

Questions to consider asking include:

Once you have agreed to go ahead with your treatment you will no doubt have many other questions about your specific treatment path.

This section provides you with information on chemotherapy and surgery, the two most commonly used types of ovarian cancer treatment. You can also read about the other types of treatment for ovarian cancer, covering radiotherapy and targeted therapies (such as PARP Inhibitors), and find out more about clinical trials.